| 摘要 |
The present specification teaches generally a therapeutic protocol for the management of inflammation in the gut and respiratory system and to reduce intracellular bacterial persistence in blood or tissue cells. Agents, medicaments, probiotics, microbial and viral delivery vehicles and therapeutic kits for use the in the therapeutic protocol are also encompassed herein. An embodiment of the agents and medicaments of the present invention relates to agents that down-regulate the expression, level, or function of toll¬ like receptor (TLR) 7 and/or 8. |
